To access this element change to forms mode OFF
Grant Award View - GA276623
Fighting Cancer Relapse: Developing an Oral Cancer Vaccine Generating...
GA ID:
GA276623
Agency:
National Health and Medical Research Council (NHMRC)
Approval Date:
1-Sep-2022
Publish Date:
19-Dec-2022
Category:
Medical Research
Grant Term:
1-Jan-2023 to 31-Dec-2027
Value (AUD):
$655,150.00
(GST inclusive where applicable)
One-off/Ad hoc:
No
Aggregate Grant Award:
No
PBS Program Name:
NHMRC 21/22 1.1 Health and Medical Research
Grant Program:
Investigator Grants
Grant Activity:
Fighting Cancer Relapse: Developing an Oral Cancer Vaccine Generating Memory T Cells
Purpose:
Colorectal cancer (CRC) is the world's second most fatal cancer with a high rate of relapse. This project aims to develop an oral vaccine for preventing CRC recurrence by boosting the local gut immune response, which is at the frontline in powerful anti-cancer defence. This oral vaccine is based on cutting-edge research in immunology and nanomaterials, enabling robust and persistent protection against CRC recurrence, and enables convenient oral intake for maximal patient acceptance.
GO ID:
GO Title:
Investigator Grants 2022
Internal Reference ID:
2022/GNT2017974
Selection Process:
Targeted or Restricted Competitive
Confidentiality - Contract:
Yes
Confidentiality Reason(s) - Contract:
Privacy Act 1988
Intellectual property
Intellectual property
Confidentiality - Outputs:
Yes
Confidentiality Reason(s) - Outputs:
Intellectual property
Grant Recipient Details
Recipient Name:
The University of Queensland
Recipient ABN:
63 942 912 684
Grant Recipient Location
Suburb:
St Lucia
Town/City:
St Lucia
Postcode:
4072
State/Territory:
QLD
Country:
AUSTRALIA
Grant Delivery Location
State/Territory:
VIC, QLD
Postcode:
Multiple
Country:
AUSTRALIA